132 related articles for article (PubMed ID: 2257310)
1. Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin.
Kwak LW; Campbell MJ; Zelenetz AD; Levy R
Blood; 1990 Dec; 76(11):2411-7. PubMed ID: 2257310
[TBL] [Abstract][Full Text] [Related]
2. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
Kwak LW; Campbell M; Levy R
Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
[TBL] [Abstract][Full Text] [Related]
3. Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy.
Kwak LW; Campbell MJ; Zelenetz AD; Levy R
Blood; 1991 Nov; 78(10):2768-72. PubMed ID: 1824269
[TBL] [Abstract][Full Text] [Related]
4. Active immunization of murine allogeneic bone marrow transplant donors with B-cell tumor-derived idiotype: a strategy for enhancing the specific antitumor effect of marrow grafts.
Kwak LW; Pennington R; Longo DL
Blood; 1996 Apr; 87(7):3053-60. PubMed ID: 8639929
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
Kwak LW; Young HA; Pennington RW; Weeks SD
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10972-7. PubMed ID: 8855293
[TBL] [Abstract][Full Text] [Related]
6. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
[TBL] [Abstract][Full Text] [Related]
7. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
Weiner GJ; Hillstrom JR
J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
[TBL] [Abstract][Full Text] [Related]
8. Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.
Neeson P; Pan ZK; Paterson Y
Cancer Immunol Immunother; 2008 Apr; 57(4):493-505. PubMed ID: 17876582
[TBL] [Abstract][Full Text] [Related]
9. A murine B cell lymphoma expressing human HER2 / neu undergoes spontaneous tumor regression and elicits antitumor immunity.
Penichet ML; Dela Cruz JS; Challita-Eid PM; Rosenblatt JD; Morrison SL
Cancer Immunol Immunother; 2001 Feb; 49(12):649-62. PubMed ID: 11258791
[TBL] [Abstract][Full Text] [Related]
10. Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma.
Davis TA; Hsu FJ; Caspar CB; van Beckhoven A; Czerwinsk DK; Liles TM; Taidi B; Benike CJ; Engleman EG; Levy R
Biol Blood Marrow Transplant; 2001; 7(9):517-22. PubMed ID: 11669219
[TBL] [Abstract][Full Text] [Related]
11. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice.
Haimovich J; Kukulansky T; Weissman B; Hollander N
Cancer Immunol Immunother; 1999 Feb; 47(6):330-6. PubMed ID: 10203063
[TBL] [Abstract][Full Text] [Related]
12. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.
Hornung RL; Longo DL; Bowersox OC; Kwak LW
J Natl Cancer Inst; 1995 Sep; 87(17):1289-96. PubMed ID: 7544833
[TBL] [Abstract][Full Text] [Related]
13. Tumor resistance induced by syngeneic bone marrow transplantation and enhanced by interleukin 2: a model for the graft versus leukemia reaction.
Kwak LW; Campbell MJ; Levy R
Cancer Res; 1992 Aug; 52(15):4117-20. PubMed ID: 1638524
[TBL] [Abstract][Full Text] [Related]
14. Induction of tumor immunity by intact irradiated leukemic B cells (BCL1) bearing a tumor-associated cell-surface idiotype and the costimulatory B7 molecule.
Morecki S; Levi S; Puyesky Y; Slavin S
Cancer Immunol Immunother; 1995 Oct; 41(4):236-42. PubMed ID: 7489566
[TBL] [Abstract][Full Text] [Related]
15. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
Kaminski MS; Kitamura K; Maloney DG; Levy R
J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide.
Campbell MJ; Esserman L; Levy R
J Immunol; 1988 Nov; 141(9):3227-33. PubMed ID: 3049819
[TBL] [Abstract][Full Text] [Related]
17. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
Zeis M; Frenzke H; Schmitz N; Uharek L; Steinmann J
Bone Marrow Transplant; 2002 Feb; 29(3):213-21. PubMed ID: 11859393
[TBL] [Abstract][Full Text] [Related]
18. Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease.
Bryson JS; Jennings CD; Lowery DM; Carlson SL; Pflugh DL; Caywood BE; Kaplan AM
Bone Marrow Transplant; 1999 Feb; 23(4):363-72. PubMed ID: 10100580
[TBL] [Abstract][Full Text] [Related]
19. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.
Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R
J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype.
Ghosh SK; White LM; Ghosh R; Bankert RB
J Immunol; 1990 Jul; 145(1):365-70. PubMed ID: 1972719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
